Article
CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders.
Human immunology - 1 Mar 2005
Rueda B, Zhernakova A, López-Nevot M A, Gomez-Garcia M, Ortega E, Piñero A, Correro F, Brieva J A, Nieto A, Koeleman B P C, Martín J
Abstract excerpt
The aim of this work was to investigate the possible influence of the recently described CT60 A/G dimorphism of the CTLA4 (cytotoxic T-lymphocyte antigen 4) gene in the susceptibility to two different autoimmune inflammatory intestinal disorders, inflammatory bowel disease (IBD) and celiac disease. We analyzed a case-control cohort composed of 528 Spanish patients with IBD (284 with Crohn disease and 244 with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
